Protein Tyrosine Kinases (PTK) in Multiple Myeloma

计划入组 10 人 · 首次发布于 2005 年 9 月 14 日

Serum TAM Receptor Tyrosine Kinase Ligands in Acute Pancreatitis

计划入组 896 人 · 首次发布于 2025 年 6 月 15 日

Prevalence of Creatinine Phosphokinase Increase in Patients With Solid Tumors Treated by Inhibitors of Tyrosine Kinases

计划入组 154 人 · 首次发布于 2010 年 11 月 25 日

cdc2-like kinases/Dyrk1A inhibitors (NCATS)

TrkB receptor-agonizing mAbs (Wyeth)

Tyrosine(Premasol, Clinimix E 2.75/5, Aminosyn-PF 7%, Primene, Clinimix 2.75/5, Trophamine 10 %, Plenamine, Olimel, Prosol, Clinisol 15, Periolimel, Travasol 10)

C₉H₁₁NO₃

Arvinas Estrogen Receptor, Inc.

United States

Arvinas Androgen Receptor, Inc.

United States

Inhibikase Therapeutics

United States

Pinetree Therapeutics Secures $47 Million Series B to Advance Novel Protein Degraders for Drug-Resistant Cancers

Cabozantinib Demonstrates Promising Results in Neuroendocrine Tumors, Analyst Recommends 'Buy' for Exelixis

Cabometyx Demonstrates Significant Efficacy in Advanced Neuroendocrine Tumors